Trial Profile
Phase II trial of ofatumumab combined with ESHAP as salvage therapy before autologous stem cell transplantation, for patients with relapsed or refractory diffuse large B cell lymphoma (DLBCL) previously treated with a rituximab based regimen
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Mar 2016
Price :
$35
*
At a glance
- Drugs Ofatumumab (Primary) ; Cisplatin; Cytarabine; Etoposide; Methylprednisolone
- Indications Diffuse large B cell lymphoma
- Focus Therapeutic Use
- 03 Mar 2016 Status changed from recruiting to completed, as reported by European Clinical Trials Database record.
- 11 Oct 2012 New trial record